Abstract
1. The cerebral topography of the action of diazepam and the action of the 5-hydroxytryptamine 5-HT3 receptor antagonists GR38032F and ICS 205-930 in attenuating an aversive response was studied in the mouse. 2. Mice which had been cannulated to allow drug injection into the dorsal and median raphe nuclei, the amygdala, nucleus accumbens or caudate-putamen were placed in a two compartment black (dimly illuminated) and white (brightly illuminated) test box. Measurements were made of the time spent, rearing and line crossings in the two sections and the latency of initial movement from the white to the black area. 3. The injection of diazepam (0.1-10 ng), GR38032F (0.01-1.0 ng) and ICS 205-930 (1.0-10 ng) into the dorsal raphe nucleus and amygdala, and the injection of diazepam (0.1-10 ng) into the median raphe nucleus, reduced an aversive response to the brightly illuminated white area, delaying the initial movement into the black section and increasing the time spent, rearings and line crossings in the white area. Concomitantly such activities were decreased in the black section. 4. The injection of the 5-HT3 agonist 2-methyl-5-hydroxytryptamine (0.1-10 ng) into the dorsal raphe nucleus and amygdala caused the opposite response, decreasing the time taken to move into the black section and increasing the time spent, rearings and line crossings in the black section, decreasing such activities in the white area.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blumstein L. K., Crawley J. N. Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1983 Jan;18(1):37–40. doi: 10.1016/0091-3057(83)90247-2. [DOI] [PubMed] [Google Scholar]
- Butler A., Hill J. M., Ireland S. J., Jordan C. C., Tyers M. B. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol. 1988 Jun;94(2):397–412. doi: 10.1111/j.1476-5381.1988.tb11542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Christmas A. J., Maxwell D. R. A comparison of the effects of some benzodiazepines and other drugs on aggressive and exploratory behaviour in mice and rats. Neuropharmacology. 1970 Jan;9(1):17–29. doi: 10.1016/0028-3908(70)90044-4. [DOI] [PubMed] [Google Scholar]
- Costall B., Domeney A. M., Gerrard P. A., Kelly M. E., Naylor R. J. Zacopride: anxiolytic profile in rodent and primate models of anxiety. J Pharm Pharmacol. 1988 Apr;40(4):302–305. doi: 10.1111/j.2042-7158.1988.tb05254.x. [DOI] [PubMed] [Google Scholar]
- Costall B., Hendrie C. A., Kelly M. E., Naylor R. J. Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacology. 1987 Feb-Mar;26(2-3):195–200. doi: 10.1016/0028-3908(87)90209-7. [DOI] [PubMed] [Google Scholar]
- Crawley J. N. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav. 1981 Nov;15(5):695–699. doi: 10.1016/0091-3057(81)90007-1. [DOI] [PubMed] [Google Scholar]
- Crawley J., Goodwin F. K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1980 Aug;13(2):167–170. doi: 10.1016/0091-3057(80)90067-2. [DOI] [PubMed] [Google Scholar]
- File S. E., Hyde J. R., MacLeod N. K. 5,7-dihydroxytryptamine lesions of dorsal and median raphé nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. J Affect Disord. 1979 Jun;1(2):115–122. doi: 10.1016/0165-0327(79)90030-2. [DOI] [PubMed] [Google Scholar]
- Gallager D. W. Benzodiazepines: potentiation of a GABA inhibitory response in the dorsal raphe nucleus. Eur J Pharmacol. 1978 May 15;49(2):133–143. doi: 10.1016/0014-2999(78)90069-9. [DOI] [PubMed] [Google Scholar]
- Geller I., Blum K. The effects of 5-HTP on para-Chlorophenylalanine (p-CPA) attenuation of "conflict" behavior. Eur J Pharmacol. 1970 Mar;9(3):319–324. doi: 10.1016/0014-2999(70)90229-3. [DOI] [PubMed] [Google Scholar]
- Jones B. J., Costall B., Domeney A. M., Kelly M. E., Naylor R. J., Oakley N. R., Tyers M. B. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist. Br J Pharmacol. 1988 Apr;93(4):985–993. doi: 10.1111/j.1476-5381.1988.tb11489.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oliverio A., Eleftheriou B. E., Bailey D. W. Exploratory activity: genetic analysis of its modification by scopolamine and amphetamine. Physiol Behav. 1973 May;10(5):893–899. doi: 10.1016/0031-9384(73)90059-0. [DOI] [PubMed] [Google Scholar]
- Richardson B. P., Engel G., Donatsch P., Stadler P. A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 1985 Jul 11;316(6024):126–131. doi: 10.1038/316126a0. [DOI] [PubMed] [Google Scholar]
- Shibata K., Kataoka Y., Gomita Y., Ueki S. Localization of the site of the anticonflict action of benzodiazepines in the amygdaloid nucleus of rats. Brain Res. 1982 Feb 25;234(2):442–446. doi: 10.1016/0006-8993(82)90884-8. [DOI] [PubMed] [Google Scholar]
- Smith C. B., Crawley J. N. Anxiolytic action of CGS 9896 on mouse exploratory behavior. Eur J Pharmacol. 1986 Dec 16;132(2-3):259–262. doi: 10.1016/0014-2999(86)90613-8. [DOI] [PubMed] [Google Scholar]
- Stein L., Wise C. D., Belluzzi J. D. Effects of benzodiazepines on central serotonergic mechanisms. Adv Biochem Psychopharmacol. 1975;(14):29–44. [PubMed] [Google Scholar]
- Thiébot M. H., Hamon M., Soubríe P. Attenuation of induced-anxiety in rats by chlordiazepoxide: role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons. Neuroscience. 1982;7(9):2287–2294. doi: 10.1016/0306-4522(82)90139-7. [DOI] [PubMed] [Google Scholar]
- Tye N. C., Everitt B. J., Iversen S. D. 5-Hydroxytryptamine and punishment. Nature. 1977 Aug 25;268(5622):741–743. doi: 10.1038/268741a0. [DOI] [PubMed] [Google Scholar]
- Tye N. C., Iversen S. D., Green A. R. The effects of benzodiazepines and serotonergic manipulations on punished responding. Neuropharmacology. 1979 Aug-Sep;18(8-9):689–695. doi: 10.1016/0028-3908(79)90036-4. [DOI] [PubMed] [Google Scholar]
